Literature DB >> 19756336

Childhood vaccination schedules in Europe vary widely. Is this a problem?

P L Lopalco1, H G de Carvalho, P Kreidl, K Leitmeyer, J Giesecke.   

Abstract

Childhood vaccination programmes in Europe are basically very safe and effective. On the other hand there are very large differences between countries in the way they are organised. In this paper we analyse the immunisation schedules used in 29 European countries to highlight similarities and differences. One of the most evident differences is the total number of doses administered under 18 years of age, which ranges between 4 and 7 if we consider DT-containing vaccines. Any change in vaccination schedules is associated with costs. Thus, this process is worthy only if it can lead in the long run to an overall improvement in the national vaccination programmes. National sovereignty in the area of vaccination programmes prevails; therefore any step forward will be feasible only if consensus in Europe is reached.

Entities:  

Mesh:

Year:  2009        PMID: 19756336     DOI: 10.1007/s00103-009-0960-z

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  3 in total

1.  How French physicians manage with a future change in the primary vaccination of infants against diphtheria, tetanus, pertussis and poliomyelitis? A qualitative study with focus groups.

Authors:  Karine Lungarde; Fanette Blaizeau; Isabelle Auger-Aubin; Daniel Floret; Serge Gilberg; Christine Jestin; Thomas Hanslik; Corinne Le Goaster; Daniel Lévy-Bruhl; Thierry Blanchon; Louise Rossignol
Journal:  BMC Fam Pract       Date:  2013-06-19       Impact factor: 2.497

Review 2.  2. How is the economic assessment of vaccines performed today?

Authors:  Baudouin Standaert; Rino Rappuoli
Journal:  J Mark Access Health Policy       Date:  2017-08-31

3.  Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years.

Authors:  Øystein Rolandsen Riise; Ida Laake; Marianne Adeleide Riise Bergsaker; Hanne Nøkleby; Inger Lise Haugen; Jann Storsæter
Journal:  BMC Pediatr       Date:  2015-11-13       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.